Trading Signals: EYES Stock Price Prediction and Forecast (Thu. Mar. 10, 2016 - Mon. Jun. 28, 2021)(Second Sight Medical Products Inc)
| EYES latest price $6.6176 (-3.81%) ($6.2400 - $6.8560) on Wed. Dec. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.07% (three month average) | RSI | 40 | Latest Price | $6.6176(-3.81%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EYES declines -1.9% a day on average for past five trading days. | Weekly Trend | EYES declines -1.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EYES advance at 0% a week (0% probability) IGOV(8%) TAN(8%) UNG(7%) FIVG(4%) FXI(4%) | Factors Impacting EYES price | EYES will decline at least -2.035% in a week (0% probabilities). BND(-8%) XLP(-6%) XLK(-6%) QQQ(-6%) LQD(-6%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.035% (StdDev 4.07%) | Hourly BBV | 0 () | Intraday Trend | 6.1% | | | |
|
Resistance Level | $6.94 | 5 Day Moving Average | $6.85(-3.39%) | 10 Day Moving Average | $6.91(-4.23%) | 20 Day Moving Average | $6.94(-4.65%) | To recent high | -13.8% | To recent low | 14% | Market Cap | $2.114b | | | | Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California. |